OncologyTube Professional - Patients Click Here
4,807 video views
Loading........
Description: Ropeginterferon Alfa-2b Induces High Rates of Clinical, Hematological and Molecular Responses in PV Patients. Two - year results from the First Prospective Randomized Controlled Trial
08:54
Ropeginterferon Alfa-2b Induces High Rates of Clinical, Hematological and Molecular Responses in PV Patients. Two - year results from the First Prospective Randomized Controlled Trial
by:PVReporter | 307 views
08:37
Advanced Forms of MPNs are Associated with Chromosomal Abnormalities Involved in Disease Progression
by:PVReporter | 199 views
12:00
Patient reported symptom burden and peripheral blood counts among PV patients.
by:PVReporter | 310 views
11:49
Dr Raajit Rampal, Memorial Sloan Kettering Cancer Center in New York City, interviews with David Wallace, PV Reporter. Discussing clinical research in MPNs at ASH 2016. Dr. Rampal presented pre-clinical data from a three drug combo in animal models.
by:PVReporter | 881 views
23:36
Dr Jean Jacques Kiladjian, Professor of Clinical Hematology, Hopital Saint-Louis, Paris, France interviews with David Wallace, PV Reporter at ASH 2016. Discussing Outcomes of Patients with MPNs after Interferon-Alph​a (IFN) Therapy Discontinuation.
by:PVReporter | 792 views

About PVReporter


Links
Channel Url: